Osaka Medical and Pharmaceutical University · Faculty of Medicine / Graduate School of Medicine · 教授

Research keywords転移性前立腺癌・去勢感受性前立腺癌・ARPI療法・ダロルタミド三剤併用療法・PSA kinetics・腎細胞癌免疫療法・転移部位別治療効果・骨転移量・発熱性好中球減少症

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Comparative efficacy of immune checkpoint inhibitor combination therapies by metastatic site in metastatic renal cell carcinoma.2026 · Scientific reports / 16 / 1
• Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple Therapy.2026 · Anticancer research / 46 / 2
• Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxel.2026 · Japanese journal of clinical oncology
• Comparison of prostate-specific antigen kinetics between androgen receptor signaling inhibitor doublet therapy and androgen receptor signaling inhibitor with docetaxel triplet therapy in patients with metastatic castration-sensitive prostate cancer.2026 · Urologic oncology / 44 / 3

• 膀胱がん治療QOL向上を目指す包括的網羅解析による治療戦略開発2025
• 副腎皮質癌の免疫逃避において機能欠損型ZNFR3が来す役割の解明2024
• がん化学放射線療法再発症例における腫瘍合成致死誘導治療法の確立2021
• 進行膀胱癌（転移を含む）に対するPDL1抗体併用硼素中性子補足療法の治療効果2021

• Official profile
• ORCID